The growing reliance on disease-modifying therapies (DMTs) to treat people with multiple sclerosis (MS) has led to fewer hospitalizations but…
Articles by Alejandra Viviescas, PhD
The New York Stem Cell Foundation (NYSCF) Research Institute and Aspen Neuroscience will…
People with relapsing-remitting multiple sclerosis (RRMS) have poorer neurite density — a measure that relates to the amount of…
SARM1 inhibitors are a potential oral treatment to slow disease progression in neurodegenerative diseases like multiple sclerosis (MS), according…
The levels of neurofilament light chain (NfL) and chitinase3-like1 (CHI3L1) in the cerebrospinal fluid — the liquid that surrounds the…
Females of certain species — like humans and mice — have a known ability to produce more of the gene …
The percentage of Taiwanese who develop multiple sclerosis (MS) after an episode of clinically isolated syndrome (CIS) is…
The Multiple Sclerosis (MS) Society of Canada closed its celebration of multiple sclerosis (MS) Awareness Month by launching…